At the time of writing, Mereo Biopharma Group Plc ADR [MREO] stock is trading at $1.8, saw in change for the day. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The MREO shares have gain 4.05% over the last week, with a monthly amount glided 3.45%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Mereo Biopharma Group Plc ADR [NASDAQ: MREO] stock has seen the most recent analyst activity on March 27, 2025, when JP Morgan initiated its Overweight rating and assigned the stock a price target of $7. Previously, Jefferies started tracking the stock with Buy rating on December 06, 2024, and set its price target to $7. On June 13, 2024, Robert W. Baird initiated with a Outperform rating and assigned a price target of $8 on the stock. Cantor Fitzgerald initiated its recommendation with a Overweight and recommended $4 as its price target on August 12, 2022. BTIG Research started tracking with a Buy rating for this stock on May 05, 2021, and assigned it a price target of $10. In a note dated April 05, 2021, Needham initiated an Buy rating and provided a target price of $10 on this stock.
For the past year, the stock price of Mereo Biopharma Group Plc ADR fluctuated between $1.47 and $4.72. Currently, Wall Street analysts expect the stock to reach $5 within the next 12 months. Mereo Biopharma Group Plc ADR [NASDAQ: MREO] shares were valued at $1.8 at the most recent close of the market. An investor can expect a potential return of 177.78% based on the average MREO price forecast.
Analyzing the MREO fundamentals
Gross Profit Margin for this corporation currently stands at 0.22% with Operating Profit Margin at -29.63%, Pretax Profit Margin comes in at -31.68%, and Net Profit Margin reading is -31.68%. To continue investigating profitability, this company’s Return on Assets is posted at -0.79, Equity is -0.8 and Total Capital is -0.84. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.7733 points at the first support level, and at 1.7467 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.8333, and for the 2nd resistance point, it is at 1.8667.
Ratios To Look Out For
It is important to note that Mereo Biopharma Group Plc ADR [NASDAQ:MREO] has a current ratio of 8.13. In addition, the Quick Ratio stands at 8.13 and the Cash Ratio stands at 7.43. Considering the valuation of this stock, the price to sales ratio is 561.18, the price to book ratio is 5.28.
